Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-11

Study Completion Date

2019-04-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The wearable vibration device aims to consistently deliver vibrations directly to the hip and spine and allowing use during many everyday activities. We propose that demonstrating higher rates of compliance and consistent delivery of optimal force, with accelerometer feedback, will provide a superior alternative to whole body vibration and is plausibly more effective at preventing bone loss in postmenopausal women than vibration platforms in the home setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Spry Belt for Improving Bone Quality

NCT03986203

Osteopenia

UNKNOWN NA

Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women

NCT00667667

Postmenopausal

TERMINATED PHASE3

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

NCT00420940

Bone Density Osteopenia Osteoporosis +1 more

COMPLETED PHASE3

"VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density

NCT00396994

Osteopenia

COMPLETED NA

The Bone-Myoregulation Reflex and Development of Sarcopenia in Osteoporosis

NCT06017245

Sarcopenia Osteoporosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this study is to demonstrate that postmenopausal women will tolerate our device, have high rates of compliance with the study protocol, receive consistently therapeutic levels of vibration and see significant effects on bone turnover based on plasma markers of bone anabolism and catabolism.

The anticipated outcomes from serum draws are an improvement in two bone turnover markers after a 30 minute treatment with the WVD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham Wearable belt

Device will be worn but not turned on for 30 minutes.

Group Type SHAM_COMPARATOR

Sham, wearing belt

Intervention Type DEVICE

The device is worn, for a specified time. It will not be turned on during this period. It is only sham.

Wearable vibration belt (30)

Device will be worn and turned on for 30 minute treatment.

Group Type EXPERIMENTAL

Wearable vibration belt

Intervention Type DEVICE

The device is worn, a wearable vibration belt, for a specified time. This will provide vibration starting at the hips.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wearable vibration belt

The device is worn, a wearable vibration belt, for a specified time. This will provide vibration starting at the hips.

Intervention Type DEVICE

Sham, wearing belt

The device is worn, for a specified time. It will not be turned on during this period. It is only sham.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female
2. Last menstrual period at least one year prior and not more than eight years prior.
3. 19 years of age and older.
4. BMD T-score at or above -2.49 at the total hip and L1-L4 spine skeletal sites as measured by DXA.
5. Ambulatory (can walk or stand without an assistive device for a minimum of 30 minutes).
6. Able to understand spoken and written English.
7. Capable and willing to follow all study-related procedures.

Exclusion Criteria

1. BMD T-score at or below -2.5 at the total hip and L1-L4 spine skeletal sites as measured by DXA.
2. A 10-year probability of hip fracture of \> 3% or major fracture of \> 20% based on results of DXA using the FRAX tool (see attached).
3. Weight \> 300 lbs.
4. Are currently taking or have taken bisphosphonates within the past 12 months, estrogen replacement therapy, or drugs affecting bone such as tamoxifen or aromatase inhibitors within the past 6 months.
5. Active cancer or cancer treatment.
6. Any change in exercise in the past 3 months.
7. Fractures or major surgery within the past 6 months.
8. Medical Implants (excluding dental implants).
9. Diagnosed with Paget's disease, heart disease, uncontrolled hypertension, renal disease, chronic fatigue syndrome, herniated disc, severe peripheral neuropathy, severe osteoarthritis.
10. Any bleeding disorder or treatment with a blood thinning medication within the last 2 years.
11. Hip circumference is greater than 42 inches

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No